Answer/comment to Prof. Tammemagi's article " Selecting lung cancer screenees using risk prediction models-where do we go from here"

Oluf Dimitri Røe^{1

2

3}

Affiliations

¹ Norwegian University of Science and Technology, Faculty of Medicine and Health Sciences, 7030 Trondheim, Norway.
² Department of Clinical Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
³ Department of Oncology, Levanger Hospital, Nord-Trøndelag Hospital Trust, N-7600 Levanger, Norway.

Comment

Oluf Dimitri Røe. Transl Lung Cancer Res. 2019 Apr.

. 2019 Apr;8(2):192-194.

doi: 10.21037/tlcr.2018.10.09.

Oluf Dimitri Røe^{1

2

3}

¹ Norwegian University of Science and Technology, Faculty of Medicine and Health Sciences, 7030 Trondheim, Norway.
² Department of Clinical Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
³ Department of Oncology, Levanger Hospital, Nord-Trøndelag Hospital Trust, N-7600 Levanger, Norway.

No abstract available

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Response to Dr. Røe's comment letter.
Tammemägi MC. Tammemägi MC. Transl Lung Cancer Res. 2019 Apr;8(2):198-199. doi: 10.21037/tlcr.2018.12.13. Transl Lung Cancer Res. 2019. PMID: 31106782 Free PMC article. No abstract available.

Selecting lung cancer screenees using risk prediction models-where do we go from here.
Tammemägi MC. Tammemägi MC. Transl Lung Cancer Res. 2018 Jun;7(3):243-253. doi: 10.21037/tlcr.2018.06.03. Transl Lung Cancer Res. 2018. PMID: 30050763 Free PMC article. Review.

1. Tammemagi MC. Selecting lung cancer screenees using risk prediction models-where do we go from here. Transl Lung Cancer Res 2018;7:243-53. 10.21037/tlcr.2018.06.03 - DOI - PMC - PubMed
1. Markaki M, Tsamardinos I, Langhammer A, et al. A Validated Clinical Risk Prediction Model for Lung Cancer in Smokers of All Ages and Exposure Types: A HUNT Study. EBioMedicine 2018;31:36-46. 10.1016/j.ebiom.2018.03.027 - DOI - PMC - PubMed
1. Weber M, Yap S, Goldsbury D, et al. Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCOm2012 risk prediction tool. Int J Cancer 2017;141:242-53. 10.1002/ijc.30673 - DOI - PubMed
1. Tammemagi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med 2013;368:728-36. 10.1056/NEJMoa1211776 - DOI - PMC - PubMed
1. Tammemagi MC, Schmidt H, Martel S, et al. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study. Lancet Oncol 2017;18:1523-31. 10.1016/S1470-2045(17)30597-1 - DOI - PubMed